' fill='%23ffffff'%3E%3Cpath d='M283.94,167.31l386.39,516.64L281.5,1104h87.51l340.42-367.76L984.48,1104h297.8L874.15,558.3l361.92-390.99 h-87.51l-313.51,338.7l-253.31-338.7H283.94z M412.63,231.77h136.81l604.13,807.76h-136.81L412.63,231.77z'%3E%3C/path%3E%3C/g%3E%3C/svg%3E%0A){kind=small}
Make it Public – new partnership will automatically register all UK clinical trials
20th October 2021
Clinical trials will be automatically registered to guarantee a full picture of research taking place in the UK, thanks to a world-first partnership launched today
The Health Research Authority (HRA) has partnered with ISRCTN, a World Health Organisation (WHO) recognised registry, to make it easy for researchers to fulfil their transparency responsibilities.
Trial registration is the first step to ensuring research transparency, and from 2022 the HRA will register clinical trials, taking the burden away from research sponsors and researchers.
The move is part of the Make it Public strategy and will ensure that information about clinical trials is publicly available for the benefit of all.
Automatic registration will start with clinical trials of new medicines, and there will be no cost to the trialists. The service will expand to cover other types of clinical trials.
The HRA will support researchers to prepare for this change. There will be detailed guidance to follow and the regulator will engage directly with networks to offer support.
Companies will continue to be offered the option to defer publication of full details for reasons of commercial sensitivity.
More information is available at www.hra.nhs.uk
